PD-L1(+) neutrophils as novel biomarkers for stage IV melanoma patients treated with nivolumab

Melanoma displays a rising incidence, and the mortality associated with metastatic form remains high. Monoclonal antibodies that block programmed death (PD-1) and PD Ligand 1 (PD-L1) network have revolutionized the history of metastatic disease. PD-L1 is expressed on several immune cells and can be...

Descripción completa

Detalles Bibliográficos
Autores principales: Cristinziano, Leonardo, Modestino, Luca, Capone, Mariaelena, Madonna, Gabriele, Mallardo, Domenico, Giannarelli, Diana, D’Angelo, Grazia, Ferrara, Anne Lise, Loffredo, Stefania, Varricchi, Gilda, Vanella, Vito, Festino, Lucia, Ascierto, Paolo Antonio, Galdiero, Maria Rosaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398490/
https://www.ncbi.nlm.nih.gov/pubmed/36016960
http://dx.doi.org/10.3389/fimmu.2022.962669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398490/
https://www.ncbi.nlm.nih.gov/pubmed/36016960
http://dx.doi.org/10.3389/fimmu.2022.962669

Ejemplares similares